Abstract
Multiple myeloma is a malignant hematological disease with a higher incidence in the elderly. The disease is considered incurable. New drugs have become available in recent years and it is expected that the availability of new drugs will increase survival. Phase III pivotal studies, however, have focused on progression-free survival, not overall survival. This is an observational cohort s…